<qa>  Docetaxel IV is administered over 30 minutes and 17-AAG as in group 1Group 2: Patients receive docetaxel IV over 30 minutes and 17-AAG as in group 1. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity. 